Logo

IDEC Extends Gene Logic Subscription

Oct 07, 2002

NEW YORK, Oct. 7-IDEC Pharmaceuticals has extended its subscription to Gene Logic's oncology database, Gene Logic said today.

 

IDEC initially subscribed to the company's Oncology DataSuite, which includes microarray-derived gene expression profiles from a variety of human cancers, in January 2000. The company will use this information to develop cancer therapies.

 

The company did not reveal financial terms of the deal

Breaking News
The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.